Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment

Brain Res. 2014 May 8;1562:39-51. doi: 10.1016/j.brainres.2014.03.016. Epub 2014 Mar 21.


Entorhinal cortex lesioning (ECL) causes an extensive deafferentation of the hippocampus that is classically followed by a compensatory reinnervation, where apolipoprotein E, the main extracellular lipid-carrier in the CNS, has been shown to play a crucial role by shuttling cholesterol to reconstructing neurons terminals. Hence, we investigated whether the ATP-binding cassette (ABC) transporters -A1 and -G1, known to regulate cellular cholesterol efflux and lipidation of the apolipoprotein E-containing lipoprotein complex are actively involved in this context of brain׳s plastic response to neurodegeneration and deafferentation. We assessed ABCA1 and ABCG1 mRNA and protein levels throughout the degenerative phase and the reinnervation process and evaluated the associated cholinergic sprouting following ECL in the adult mouse brain. We subsequently tested the effect of the pharmacological activation of the nuclear receptor LXR, prior to versus after ECL, on hippocampal ABCA1 and G1 expression and on reinnervation. ECL induced a time-dependent up-regulation of ABCA1, but not G1, that coincided with a significant increase in acetylcholine esterase (AChE) activity in the ipsilateral hippocampus. Pre-ECL, but not post-ECL i.p. treatment with the LXR agonist TO901317 also led to a significant increase solely in hippocampal ABCA1 expression, paralleled by increases in both AchE and synaptophysin protein levels in the deafferented hippocampus. Thus, ABCA1 and -G1 are differentially regulated in the lesioned brain and upon treatment with an LXR agonist. Further, TO901317-induced up-regulation of ABCA1 appears to be more beneficial in a prevention (pre-lesion) than rescue (post-lesion) treatment; both findings support a central role for ABC transporters in brain plasticity.

Keywords: ATP-binding cassette transporter; Apolipoprotein E; Cholesterol; LXR; Reinnervation; TO901317.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter 1 / genetics*
  • ATP Binding Cassette Transporter 1 / metabolism
  • ATP Binding Cassette Transporter, Subfamily G, Member 1
  • ATP-Binding Cassette Transporters / genetics*
  • ATP-Binding Cassette Transporters / metabolism
  • Acetylcholinesterase / metabolism
  • Animals
  • Entorhinal Cortex / drug effects
  • Entorhinal Cortex / injuries*
  • Entorhinal Cortex / pathology
  • Frontal Lobe / drug effects
  • Frontal Lobe / metabolism
  • Functional Laterality
  • GPI-Linked Proteins / metabolism
  • Gene Expression / drug effects
  • Hippocampus / drug effects*
  • Hippocampus / metabolism*
  • Hippocampus / pathology
  • Hippocampus / physiology
  • Hydrocarbons, Fluorinated / pharmacology
  • Lipoproteins / genetics*
  • Lipoproteins / metabolism
  • Liver X Receptors
  • Male
  • Mice, Inbred C57BL
  • Neuronal Plasticity / drug effects
  • Neuroprotective Agents / pharmacology
  • Orphan Nuclear Receptors / agonists*
  • Orphan Nuclear Receptors / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Sulfonamides / pharmacology
  • Synaptophysin / metabolism
  • Time Factors


  • ABCA1 protein, mouse
  • ABCG1 protein, mouse
  • ATP Binding Cassette Transporter 1
  • ATP Binding Cassette Transporter, Subfamily G, Member 1
  • ATP-Binding Cassette Transporters
  • GPI-Linked Proteins
  • Hydrocarbons, Fluorinated
  • Lipoproteins
  • Liver X Receptors
  • Neuroprotective Agents
  • Orphan Nuclear Receptors
  • RNA, Messenger
  • Sulfonamides
  • Synaptophysin
  • Syp protein, mouse
  • TO-901317
  • Acetylcholinesterase
  • Ache protein, mouse